Jula Inrig

Jula Inrig

Chief Tech/Sci/R&D Officer at TRAVERE THERAPEUTICS, INC.

Net worth: 7 M $ as of 2026-08-30

51 year
Consumer Services
Technology Services
Health Technology

Profile

Jula Inrig is currently Chief Medical Officer, EVP-Research & Development at Travere Therapeutics, Inc., starting in 2026.
Former positions include Director at Kidney Health Initiative from 2013 to 2018 and Global Head-Renal Center of Excellence at IQVIA, Inc. from 2017 to 2021.
Education includes undergraduate studies at California State University-Sacramento, a doctorate from Loma Linda University, and graduate studies at Duke University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-21 112,770 ( 0.12% ) 7 M $ 2026-08-30

Jula Inrig active positions

CompaniesPositionStart
TRAVERE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2022-01-03

Former positions of Jula Inrig

CompaniesPositionEnd
IMS HEALTH, INC. Corporate Officer/Principal 2021-11-30
Kidney Health Initiative
Director/Board Member 2017-12-31
See the detail of Jula Inrig's experience

Training of Jula Inrig

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

34

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Technology Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Kidney Health Initiative

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!